Key facts
- Affinity Asset Advisors is a hedge fund based in New York, New York with 2 tracked portfolio companies.
- Notable positions include Odyssey Therapeutics, TRexBio.
- Affinity Asset Advisors reports $392.1M in regulatory assets under management across 1 private fund, per its SEC Form ADV (2026-03).
About Affinity Asset Advisors
Founded in 2017
Registered with the SEC
Form ADV · 2026-03 · CRD 312788- Regulatory AUM
- $392.1M
- Private fund assets
- $1.7B
- Private funds
- 1 · 1 hedge
- Staff
- 10
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as AFFINITY ASSET ADVISORS, LLC).
Free account
See the whole book
- ·Watchlist + alerts for Affinity Asset Advisors's activity
Create free account
No card required
Portfolio, priced
2 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Odyssey Therapeutics | Biotechnology | $638.2M | — | |
| TRexBio | — | $274.0M | — |
Frequently asked
- What companies does Affinity Asset Advisors invest in?
- Affinity Asset Advisors has 2 recorded portfolio companies, including Odyssey Therapeutics, TRexBio.
- What is Affinity Asset Advisors's AUM?
- Affinity Asset Advisors manages approximately $392.1M in assets.